Pins matching tag:Deal

On 8 February 2022 NVIDIA and SoftBank Group announced they had ended NVIDIA's planned purchase of Arm Limited because of significant regulatory challenges, and SoftBank said it would prepare an Arm public offering.

On 21 September 2023 Cisco and Splunk announced a definitive agreement for Cisco to acquire the data-analytics and security software maker for US$157 a share in cash, about US$28 billion in equity value.

On 18 March 2024 Cisco closed its purchase of Splunk for US$157 a share in cash, about US$28 billion in equity value, the largest acquisition in the networking giant's history.

On 4 March 2025 CK Hutchison announced an agreement in principle to sell its ports, including the Balboa and Cristobal terminals at the ends of the Panama Canal, to a BlackRock and MSC-linked consortium. The deal was valued at 22.8 billion dollars.

On 24 September 2025 Citigroup announced that a company owned by Mexican businessman Fernando Chico Pardo agreed to buy 25% of Banamex for about MXN 42 billion (about US$2.3 billion), a major step in its divestiture of the Mexican bank.

On 1 December 2025 Goldman Sachs agreed to buy Innovator Capital Management, a provider of defined-outcome ETFs with US$28 billion under supervision, for about US$2 billion.

On 7 January 2026 Merck announced the completion of its cash tender offer for Cidara Therapeutics at US$221.50 per share, gaining CD388, a long-acting antiviral for preventing influenza.

On 11 March 2026 Google closed its all-cash US$32 billion purchase of cloud security company Wiz, its largest acquisition ever, a year after announcing it; Wiz joins Google Cloud under its own brand.

On 25 March 2026 Merck agreed to acquire Terns Pharmaceuticals for US$53.00 per share in cash, about US$6.7 billion, to get TERN-701, an oral allosteric BCR::ABL1 inhibitor for chronic myeloid leukemia.

On 9 June 2026 GSK agreed to acquire Nasdaq-listed Nuvalent for US$10.6 billion, adding two late-stage ROS1 and ALK lung cancer drugs under FDA review.

On 22 June 2026 AbbVie agreed to acquire Apogee Therapeutics for US$135.11 per share in cash, a total equity value of about US$10.9 billion, adding the IL-13 antibody zumilokibart for atopic dermatitis.

On 25 June 2026 Merck KGaA agreed to acquire Minneapolis-based Bio-Techne for US$73 per share in cash, an enterprise value of US$11.3 billion, with closing expected by late 2026 or early 2027.

On 30 July 2026 Intercontinental Exchange announced a definitive agreement to acquire the fixed-income trading platform MarketAxess for US$167 a share in cash, an equity value of about US$6.0 billion, expected to close in the first half of 2027.

On 12 August 2026 Goldman Sachs announced an agreement to acquire NEOS Investments, an options-based income ETF provider managing US$30 billion, for up to US$2.25 billion in cash and equity.

On 18 August 2026 Goldman Sachs announced an agreement to acquire LCN Capital Partners, a triple net lease and sale-leaseback manager with about US$3 billion under supervision, for up to about US$410 million.

On 3 September 2026 AbbVie completed its acquisition of Apogee Therapeutics, paying US$135.11 per share in cash for a total equity value of about US$10.9 billion.